Literature DB >> 9585201

Six decades of vaccine development--a personal history.

M R Hilleman1.   

Abstract

Mesh:

Substances:

Year:  1998        PMID: 9585201     DOI: 10.1038/nm0598supp-507

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  9 in total

1.  Rapid antibody responses by low-dose, single-step, dendritic cell-targeted immunization.

Authors:  H Wang; M N Griffiths; D R Burton; P Ghazal
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

Review 2.  What Are the Most Powerful Immunogen Design Vaccine Strategies? A Structural Biologist's Perspective.

Authors:  Peter D Kwong
Journal:  Cold Spring Harb Perspect Biol       Date:  2017-11-01       Impact factor: 10.005

3.  Immune modulating effect by a phosphoprotein-deleted rabies virus vaccine vector expressing two copies of the rabies virus glycoprotein gene.

Authors:  Jonathan Cenna; Gene S Tan; Amy B Papaneri; Bernhard Dietzschold; Matthias J Schnell; James P McGettigan
Journal:  Vaccine       Date:  2008-09-18       Impact factor: 3.641

4.  New dimensions in vaccinology: A new insight.

Authors:  D Tomar; V Chattree; V Tripathi; A A Khan; A R Bakshi; D N Rao
Journal:  Indian J Clin Biochem       Date:  2005-01

5.  Bursopentine as a novel immunoadjuvant enhances both humoral and cell-mediated immune responses to inactivated H9N2 Avian Influenza virus in chickens.

Authors:  Deyuan Li; Maoyun Xue; Chen Wang; Junbao Wang; Puyan Chen
Journal:  Clin Vaccine Immunol       Date:  2011-07-27

Review 6.  Why does drug resistance readily evolve but vaccine resistance does not?

Authors:  David A Kennedy; Andrew F Read
Journal:  Proc Biol Sci       Date:  2017-03-29       Impact factor: 5.349

Review 7.  Microneedle arrays integrated with living organisms for smart biomedical applications.

Authors:  Bo Cai; Yusheng Gong; Zheng Wang; Lin Wang; Wei Chen
Journal:  Theranostics       Date:  2021-10-25       Impact factor: 11.556

8.  Enhanced Immune Responses in Mice Induced by the c-di-GMP Adjuvanted Inactivated Vaccine for Pseudorabies Virus.

Authors:  Liting Hou; Xiaoming Yu; Yuanyuan Zhang; Luping Du; Yuanpeng Zhang; Haiwei Cheng; Qisheng Zheng; Jin Chen; Jibo Hou
Journal:  Front Immunol       Date:  2022-03-31       Impact factor: 7.561

9.  Recombinant rabies virus as potential live-viral vaccines for HIV-1.

Authors:  M J Schnell; H D Foley; C A Siler; J P McGettigan; B Dietzschold; R J Pomerantz
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.